NCT00700830View on ClinicalTrials.gov

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

1,976

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Initial dosage and the following dosages will be prescribed by the physician as a result of a normal clinical evaluation

Trial Locations (1)

16035

Algiers

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY